ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Optimizing Nivolumab Efficacy: The Role of Dosing Time in Advanced Non-Small Cell Lung Cancer.
Mustafa ErsoyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it